Invention Grant
- Patent Title: Method for genetically modifying mouse embryonic stem cell by homologous recombination
- Patent Title (中): 通过同源重组遗传修饰小鼠胚胎干细胞的方法
-
Application No.: US11809473Application Date: 2007-06-01
-
Publication No.: US08759105B2Publication Date: 2014-06-24
- Inventor: Aris N. Economides , Andrew J. Murphy , David M. Valenzuela , David Frendewey , George D. Yancopoulos
- Applicant: Aris N. Economides , Andrew J. Murphy , David M. Valenzuela , David Frendewey , George D. Yancopoulos
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Foley Hoag LLP
- Agent Brendan T. Jones
- Main IPC: A01K67/027
- IPC: A01K67/027 ; C12N15/00 ; C12N15/90 ; C12N15/79

Abstract:
A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
Public/Granted literature
- US20090055943A1 Methods of modifying eukaryotic cells Public/Granted day:2009-02-26
Information query